# Baby Vaccine Study (Sched3)

> **NCT02482636** · PHASE2 · COMPLETED · sponsor: **University of Oxford** · enrollment: 189 (actual)

## Conditions studied

- Infectious Diseases

## Interventions

- **BIOLOGICAL:** DTaP/IPV/Hib vaccine
- **BIOLOGICAL:** 13 valent Pneumococcal Conjugate Vaccine
- **BIOLOGICAL:** Rotavirus vaccine
- **BIOLOGICAL:** 4-component Meningococcal B vaccine
- **BIOLOGICAL:** Meningococcal C/Hib vaccine (MenC/Hib vaccine)
- **BIOLOGICAL:** Measles/Mumps/Rubella Vaccine (MMR vaccine)

## Key facts

- **NCT ID:** NCT02482636
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2017-11-01
- **Final completion:** 2021-06
- **Target enrollment:** 189 (ACTUAL)
- **Last updated:** 2021-09-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02482636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02482636, "Baby Vaccine Study (Sched3)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02482636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*